美女高潮喷水白浆后入在线观看_出a级黑粗大硬长爽猛视频_qvod日韩伦理电影_亚洲自偷自拍三级_成人黄片视频_精品综合无码在线观看_亚洲综合无码中文字幕伊人_亚洲男人天堂最新版_夫洗澡公强我了60分钟_免费看又爽又黄又猛的视频

尿溶蛋白2(UPK2)多克隆抗體

Polyclonal Antibody to Uroplakin 2 (UPK2)

UPII; Uroplakin II

  • 尿溶蛋白2(UPK2)多克隆抗體 產(chǎn)品包裝(模擬)
  • 尿溶蛋白2(UPK2)多克隆抗體 產(chǎn)品包裝(模擬)
  • 尿溶蛋白2(UPK2)多克隆抗體 DAB staining on IHC-P; Sample: Rat Bladder Tissue; Primary Ab: 20ug/ml Rabbit Anti-Human UPK2 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • PAF561Hu01.jpg Figure. Western Blot; Sample: Recombinant UPK2, Human.
  • 尿溶蛋白2(UPK2)多克隆抗體 Western Blot; Sample: Human Urine
    Primary Ab: 1μg/ml Rabbit Anti-Human UPK2 Antibody
    Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • 尿溶蛋白2(UPK2)多克隆抗體 Western Blot; Samples: Lane1: Rat Bladder lysate; Lane2: Mouse Bladder lysate;
    Primary Ab: 1μg/ml Rabbit Anti-Human UPK2 Antibody
    Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
    (Catalog: SAA544Rb19)
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對(duì)UPK2的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別UPK2。

用法

Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲(chǔ)存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

贈(zèng)品

相關(guān)產(chǎn)品

編號(hào) 適用物種:Homo sapiens (Human,人) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
URPF561Hu01 尿溶蛋白2(UPK2)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UPAF561Hu01 尿溶蛋白2(UPK2)多克隆抗體 WB; IHC
ULAF561Hu61 尿溶蛋白2(UPK2)多克隆抗體(吲哚菁綠標(biāo)記) WB; IHC; ICC; IF.
USEF561Hu 尿溶蛋白2(UPK2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
ULMF561Hu 尿溶蛋白2(UPK2)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志 參考文獻(xiàn)
BioMed Research International Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer []
. Initial Evaluation of Uroplakins UPIIIa and UPII in Selected Benign Urological Diseases [34944460]
留言咨詢